Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Omnipod® 5 App for iPhone® Now Fully Available in the United States
04:01pm, Tuesday, 29'th Oct 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Expanded collaborations to support rapid testing in advanced animal models in Q4 2024 Expanded collaborations to support rapid testing in advanced animal models in Q4 2024
Is Insulet Stock a Smart Addition to Your Portfolio Right Now?
10:10am, Wednesday, 23'rd Oct 2024
PODD continues to make strides with Omnipod 5 and its market expansion. Robust solvency is a plus.
PAHC vs. PODD: Which Stock Is the Better Value Option?
12:46pm, Tuesday, 22'nd Oct 2024
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
Profitable S&P 500 Stocks to Buy in a Strong Q4: NVIDIA & 2 Others
04:05pm, Monday, 21'st Oct 2024
NVIDIA, Insulet and Monolithic Power Systems have been selected as the top picks with a high net income ratio.
National Campaign Launches to Combat Diabetes Stigma Using Comedy
09:00am, Thursday, 10'th Oct 2024
SAN FRANCISCO , Oct. 10, 2024 /PRNewswire/ -- The Spoonful of Laughter campaign is a national initiative using comedy to educate about diabetes, counter harmful stereotypes and stigma, and amplify aut
HLN or PODD: Which Is the Better Value Stock Right Now?
12:46pm, Thursday, 03'rd Oct 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Haleon PLC Sponsored ADR (HLN) and Insulet (PODD). But which of these two stocks is more attractive to
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
06:00am, Monday, 30'th Sep 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
BAX vs. PODD: Which Stock Should Value Investors Buy Now?
12:46pm, Monday, 16'th Sep 2024
Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Insulet (PODD). But which of these two stocks is more attractive to valu
Upstart, Insulet And 2 Other Stocks Executives Are Selling
07:44am, Thursday, 12'th Sep 2024
The Nasdaq 100 closed higher by over 400 points during Wednesday's session. Investors, meanwhile, focused on some notable insider trades.
Should You Continue to Retain PODD Stock in Your Portfolio Now?
08:26am, Wednesday, 04'th Sep 2024
Insulet's Omnipod 5 is set to drive growth in the upcoming quarters. Meanwhile, the stock is facing challenges due to economic uncertainties.
What Helped Insulet Stock Gain 10% This Week?
09:00am, Friday, 30'th Aug 2024
Insulet stock (NASDAQ: PODD) currently trades around $200 per share, about 35% lower than the levels of over $300 seen in early November 2021. In comparison, its peer – DexCom stock – is down 55%
Why Insulet Stock Was Zooming Higher This Week
07:20am, Friday, 30'th Aug 2024
The highly specialized medical device maker earns an important nod from a top regulator. A label expansion could potentially reach a market of 6 million people.
S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index
06:35pm, Tuesday, 27'th Aug 2024
Major U.S. equities indexes ticked higher ahead of a potentially consequential earnings report from semiconductor giant Nvidia (NVDA) as well as key inflation and economic data set for release later i
Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes
11:55am, Tuesday, 27'th Aug 2024
PODD marks a major milestone with Omnipod 5 approval for the treatment of type 2 diabetes.
